@article{9440ccc7d1004059a61c4af857955b21,
title = "Potential of Inaccurate Cefiderocol Susceptibility Results: a CLSI AST Subcommittee Advisory",
keywords = "Clinical and Laboratory Standards Institute, antimicrobial susceptibility testing, cefiderocol",
author = "{the Clinical and Laboratory Standards Institute Antimicrobial Susceptibility Testing Subcommittee} and Simner, {Patricia J.} and Palavecino, {Elizabeth L.} and Satlin, {Michael J.} and Mathers, {Amy J.} and Weinstein, {Melvin P.} and Lewis, {James S.} and Romney Humphries",
note = "Funding Information: All authors are members of the Clinical and Laboratory Standards Institute Antimicrobial Susceptibility Testing Subcommittee. P.J.S., M.J.S., and R.H. are consultants to Shionogi, Inc. R.H. is a consultant for QPex, Melinta, and Ventorx. M.J.S. discloses grant support from BioFire Diagnostics, Merck, Selux Diagnostics, and Affinity Biosensors and is a member of an Independent Data Monitoring Committee for AbbVie. P.J.S. reports grants and personal fees from OpGen, Inc., bioM{\'e}rieux, Inc., and BD Diagnostics; grants from Affinity Biosensors and Qiagen; and personal fees from GeneCapture and Entasis outside the submitted work.",
year = "2023",
month = apr,
doi = "10.1128/jcm.01600-22",
language = "English (US)",
volume = "61",
journal = "Journal of clinical microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "4",
}